Reza Taheri
Papers
3
Total Citations
12
H-Index
2
About
Dr. Reza Taheri is a pioneering head and neck surgical oncologist whose work centers on de-escalating treatment for oropharyngeal squamous cell carcinoma (OPSCC) to reduce long-term toxicity. His major contribution is the development and validation of a novel treatment paradigm that combines induction chemotherapy with transoral robotic surgery (TORS), aiming to eliminate the need for adjuvant radiation and its associated lifelong morbidity. Through a series of phase II studies (2017–2019), Dr. Taheri demonstrated that this approach can achieve definitive disease control while sparing patients from the debilitating effects of chemoradiation. His work has garnered over a dozen citations and represents a significant shift toward function-preserving, patient-centered care in head and neck oncology. Dr. Taheri’s research directly addresses a critical gap in standard treatment, offering a promising alternative for locally advanced OPSCC. His dedication to improving quality of life through surgical innovation marks him as a leading voice in the movement toward personalized, de-escalated therapy.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3